NASDAQ:RLAY
Relay Therapeutics Inc. Stock News
$6.42
+0.110 (+1.74%)
At Close: May 10, 2024
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
06:00am, Monday, 14'th Dec 2020
Collaboration brings together clinical stage SHP2 and KRAS G12C inhibitors
Relay Therapeutics Reports Third Quarter 2020 Financial Results
04:05pm, Thursday, 12'th Nov 2020
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalle
